fda glp-1 warning letters news Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA targets more online vendors

Inflammatory response in the pathogenesis and treatment of hepatocellular carcinoma: a double-edged weapon

Cerovecki et al

GPx activity and treatment response Prepost change in GPx activity was negatively associated with prepost change in LSAS-SR, indicating that patients with increased GPx activity showed greater reduction of social anxiety (Adj- R 2 = 0.05, = 0.28, B = 0.26, BSE = 0.11, Z = 2.34, p = 0.024

Individualized Dosing Strategies Traditional vitamin D dosing has relied on population-based recommendations that fail to account for individual variation

New insights into calorie restriction induced bone loss

Safety Considerations Contraindications to the use of GLP-1 RAs must be considered when making a prescribing decision